Clinical and molecular characterization of thyroid cancer when seen as a second malignant neoplasm
Background: Second malignant neoplasms (SMN) are among the most serious long-term adverse health conditions in cancer survivors. The aim of this study was to characterize clinical findings of patients who developed thyroid cancers as SMN, and to examine genomic alterations in thyroid cancer tissue....
Guardado en:
Autores principales: | Kristen Romanelli, Justin Wells, Aneeta Patel, Maria Mendonca Torres, John Costello, Kirk Jensen, Vasyl Vasko |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SAGE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/15c8db2c2ab54d238316cb7fb8854014 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Overexpression of PAX8-AS1 Inhibits Malignant Phenotypes of Papillary Thyroid Carcinoma Cells via miR-96-5p/PKN2 Axis
por: Ping Zhou, et al.
Publicado: (2021) -
Two Cases of Armour Thyroid Interference in Thyroglobulin Monitoring for Thyroid Cancer
por: Michelle Ponder, et al.
Publicado: (2021) -
Association of Phthalate Exposure with Thyroid Function and Thyroid Homeostasis Parameters in Type 2 Diabetes
por: Yi Chen, et al.
Publicado: (2021) -
Recurrent Macroprolactinoma with Malignant Conversion to Carcinoma with Spinal Metastasis
por: Madeline Mori, et al.
Publicado: (2021) -
Altered Thyroid Function Tests Observed in Hypophosphatasia Patients Treated with Asfotase Alfa
por: Hajime Kato, et al.
Publicado: (2021)